155
Views
4
CrossRef citations to date
0
Altmetric
Case Study

A delayed injection-site reaction in a patient receiving extended-release naltrexone

, MD, , MD, MPH, , MD, , RN & , MD, PhD

References

  • Bouchery EE, Harwood HJ, Sacks JJ, Simon CJ, Brewer RD. Economic costs of excessive alcohol consumption in the U.S., 2006. Am J Prev Med. 2011;41:516–524.
  • Jonas DE, Amick HR, Feltner C, et al. Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. JAMA. 2014;311:1889–1900.
  • Maisel NC, Blodgett JC, Wilbourne PL, Humphreys K, Finney JW. Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: When are these medications most helpful? Addiction. 2013;108:275–293.
  • Swift R, Oslin DW, Alexander M, Forman R. Adherence Monitoring in Naltrexone Pharmacotherapy Trials: A Systematic Review*. Journal of studies on alcohol and drugs. 2011 Nov;72(6):1012–8.
  • Warren KR, Hewitt BG. NIAAA: Advancing alcohol research for 40 years. Alcohol Health & Research World. 2010 Jan 1;33(1):5.
  • Collins SE, Grazioli VS, Torres NI, et al. Qualitatively and quantitatively evaluating harm-reduction goal setting among chronically homeless individuals with alcohol dependence. Addict Behav. 2015;45:184–190.
  • Bryson WC, McConnell KJ, Korthuis PT, McCarty D. Extended-release naltrexone for alcohol dependence: persistence and healthcare costs and utilization. The American journal of managed care. 2011 Jun;17(Suppl 8):S222.
  • Food and Drug Administration. Information for Healthcare Professionals: Naltrexone Injection Site Reactions (Naltrexone for Extended-Release Injectable Suspension, marketed as Vivitrol). Rockville, MD: Food and Drug Administration; 2008.
  • Mason BJ, Quello S, Goodell V, Shadan F, Kyle M, Begovic A. Gabapentin treatment for alcohol dependence: A randomized clinical trial. JAMA Intern Med. 2014;174:70–77.
  • Gastfriend DR. Intramuscular extended-release naltrexone: Current evidence. Ann N Y Acad Sci. 2011;1216:144–166.
  • Goonoo N, Bhaw-Luximon A, Ujoodha R, Jhugroo A, Hulse GK, Jhurry D. Naltrexone: A review of existing sustained drug delivery systems and emerging nano-based systems. J Controlled Release. 2014;183:154–166.
  • Stokes SC, Tankersley MS. HIV: Practical implications for the practicing allergist–immunologist. Ann Allergy Asthma Immunol. 2011;107:1–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.